Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 -0.295M
December 31, 2025 0.038M
September 30, 2025 -3.485M
June 30, 2025 -18.78M
March 31, 2025 -0.198M
December 31, 2024 0.00
September 30, 2024 -0.094M
June 30, 2024 0.00
March 31, 2024 -0.104M
December 31, 2023 0.00
September 30, 2023 -0.127M
June 30, 2023 0.00
March 31, 2023 -0.179M
December 31, 2022 -0.061M
September 30, 2022 -0.154M
June 30, 2022 0.00
March 31, 2022 -0.231M
December 31, 2021 0.031M
September 30, 2021 -0.248M
June 30, 2021 0.186M
March 31, 2021 -65.18M
December 31, 2020 -0.001M
Date Value
September 30, 2020 -0.142M
June 30, 2020 -0.02M
March 31, 2020 -0.01M
December 31, 2019 1.747M
September 30, 2019 -70.62M
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 -2.716M
December 31, 2015 -0.004M
September 30, 2015 0.057M
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 -0.096M
September 30, 2014 -0.098M
June 30, 2014 -0.001M
March 31, 2014 0.00
December 31, 2013 -2.509M
September 30, 2013 -0.002M
June 30, 2013 -0.02M
March 31, 2013 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. -2.80M
BioRestorative Therapies, Inc. -4.441M
CareDx, Inc. 9.481M
Natera, Inc. -17.30M
Sera Prognostics, Inc. -0.14M